Focus on Orphan Drug Development and Predictive Medicine
inThought Research.
Answers to out plan, out maneuver, and out market.
The inThought team delivers forward-looking analyses to healthcare professionals as well as to institutional investors. Analyses include a proprietary methodology for quantifying probability of FDA approval as well as a forecasting revenue methodology for both approved and develop-mental drugs and medical devices. Both the probability of approval models and revenue models are being integrated into the Wolters Kluwer Adis R&D Insight™ (RDI) product.
Request a Free Trial
Sign up for a free trial subscription that includes access to research alerts, expert calls, regional implications, ask the expert, and access to the inThought Library.
Research Examples
RESEARCH ALERT:
-
-
-
-
-
-
-
Kinase Inhibitors
-
-
-
-
-
Expert Calls
-
Alzheimer Drugs Call
-
Ben Weintraub featured on WLW-AM's "Doc Thompson" show
-
Genetics in Medicine Call
In The Press
-
December 21, 2011
-
November 3, 2011
-
October 25, 2011